Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
David Dai's Stock Ratings
UBS Analyst
David Dai is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/16/2025
Updated: Dec 16, 2025
Overall Average Return
-0.27%
Smart Score
Overall Average Return Percentile
32nd
Number of Ratings
36
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/21/2025 | CATX | Buy Now | Perspective Therapeutics | $2.52 | 177.78% | $18 → $7 | Maintains | Buy | Get Alert | |
| 11/14/2025 | KURA | Buy Now | Kura Oncology | $10.58 | 51.23% | $14 → $16 | Maintains | Buy | Get Alert | |
| 11/06/2025 | BNTX | Buy Now | BioNTech | $93.81 | 24.72% | $115 → $117 | Maintains | Neutral | Get Alert | |
| 11/04/2025 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | 82.5% | $35 → $38 | Maintains | Buy | Get Alert | |
| 10/31/2025 | NUVL | Buy Now | Nuvalent | $104.86 | 25.88% | $114 → $132 | Maintains | Buy | Get Alert | |
| 09/30/2025 | MRUS | Buy Now | Merus | $96.83 | 0.18% | $72 → $97 | Downgrade | Buy → Neutral | Get Alert | |
| 09/23/2025 | TLX | Buy Now | Telix Pharmaceuticals | $8.41 | 137.81% | $23 → $20 | Maintains | Buy | Get Alert | |
| 07/15/2025 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | 68.09% | $37 → $35 | Maintains | Buy | Get Alert | |
| 07/10/2025 | NRIX | Buy Now | Nurix Therapeutics | $19.25 | 35.06% | $30 → $26 | Maintains | Buy | Get Alert | |
| 07/01/2025 | SMMT | Buy Now | Summit Therapeutics | $17.22 | 74.2% | → $30 | Initiates | → Buy | Get Alert | |
| 06/05/2025 | BPMC | Buy Now | Blueprint Medicines | — | — | $88 → $129 | Maintains | Neutral | Get Alert | |
| 05/16/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $2.15 | -6.99% | $17 → $2 | Downgrade | Buy → Neutral | Get Alert | |
| 05/12/2025 | CGEM | Buy Now | Cullinan Therapeutics | $10.66 | 125.14% | $30 → $24 | Maintains | Buy | Get Alert | |
| 03/14/2025 | NUVL | Buy Now | Nuvalent | $104.86 | -4.63% | $100 → $100 | Upgrade | Neutral → Buy | Get Alert | |
| 03/06/2025 | KURA | Buy Now | Kura Oncology | $10.58 | 32.33% | $27 → $14 | Maintains | Buy | Get Alert | |
| 10/24/2024 | IMCR | Buy Now | Immunocore Hldgs | $36.02 | -33.37% | → $24 | Initiates | → Sell | Get Alert | |
| 10/24/2024 | NUVL | Buy Now | Nuvalent | $104.86 | -4.63% | → $100 | Initiates | → Neutral | Get Alert | |
| 10/24/2024 | BPMC | Buy Now | Blueprint Medicines | — | — | → $88 | Initiates | → Neutral | Get Alert | |
| 10/24/2024 | CATX | Buy Now | Perspective Therapeutics | $2.52 | 693.65% | → $20 | Initiates | → Buy | Get Alert | |
| 10/24/2024 | NRIX | Buy Now | Nurix Therapeutics | $19.25 | 81.82% | → $35 | Initiates | → Buy | Get Alert | |
| 10/24/2024 | MRUS | Buy Now | Merus | $96.83 | -25.64% | → $72 | Initiates | → Buy | Get Alert | |
| 10/24/2024 | KURA | Buy Now | Kura Oncology | $10.58 | 155.2% | → $27 | Initiates | → Buy | Get Alert | |
| 10/24/2024 | JANX | Buy Now | Janux Therapeutics | $15.12 | 356.35% | → $69 | Initiates | → Buy | Get Alert | |
| 10/24/2024 | IDYA | Buy Now | IDEAYA Biosciences | $33.00 | 51.52% | → $50 | Initiates | → Buy | Get Alert | |
| 10/24/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $2.15 | 690.59% | → $17 | Initiates | → Buy | Get Alert | |
| 10/24/2024 | CGEM | Buy Now | Cullinan Therapeutics | $10.66 | 181.43% | → $30 | Initiates | → Buy | Get Alert | |
| 10/24/2024 | CGON | Buy Now | CG Oncology | $39.75 | 50.94% | → $60 | Initiates | → Buy | Get Alert | |
| 10/24/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | 77.7% | → $37 | Initiates | → Buy | Get Alert | |
| 02/24/2023 | JNCE | Buy Now | Jounce Therapeutics | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 03/31/2022 | ACET | Buy Now | Adicet Bio | $0.49 | 5579.51% | → $28 | Initiates | → Outperform | Get Alert | |
| 03/16/2022 | INBX | Buy Now | Inhibrx | $76.39 | -47.64% | → $40 | Initiates | → Outperform | Get Alert | |
| 03/16/2022 | JNCE | Buy Now | Jounce Therapeutics | — | — | → $17 | Initiates | → Outperform | Get Alert | |
| 02/04/2022 | MGNX | Buy Now | Macrogenics | $1.35 | 2862.96% | → $40 | Initiates | → Outperform | Get Alert | |
| 11/18/2021 | NKTX | Buy Now | Nkarta | $1.84 | 2617.39% | → $50 | Initiates | → Outperform | Get Alert | |
| 03/17/2020 | JD | Buy Now | JD.com | $28.43 | 82.93% | $41 → $52 | Upgrade | Market Perform → Outperform | Get Alert | |
| 04/25/2017 | SNE | Buy Now | Sony | — | — | → $41 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved